VNV Global Personalised Medicine Investors

VNV Global is an investment company with the business concept of using experience, expertise and a widespread network to identify and invest in assets with considerable potential for value appreciation. The company has a special focus on online marketplaces and businesses with strong network effects. The common shares of VNV Global are listed on Nasdaq Stockholm, Mid Cap segment, with the ticker VNV.



Investors Number: 83
Industry: Health Tech
Investor Type: Technology - oriented Investor with Venture Investment Focus
Headquarters: Stockholm, Stockholms Lan, Sweden
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed
Funding Status: IPO
Employee Number: 1-10
Number Of Exists: 8
Technology: Assistive technologies
Estimated Revenue: $1M to $10M
Acquisitions Number: 51
Founded Date: 2007-01-01